Potential therapeutic applications of fructose-1,6-diphosphate

Expert Opinion on Investigational Drugs

Volumn 7, Issue 4, 1998, Pages 615-623

  Marangos, Paul J ^a   Fox, Anthony W ^a   Riedel, Bernhard J ^a   Royston, David ^a   Dziewanowska, Zofia E ^a  

^a Cypros Pharmaceutical Corporation   (United States)

Author keywords

6 diphosphate; bypass surgery; fructose 1; ishaemia; myocardial infarction; sickle cell anaemia

Indexed keywords

EID: 9744242946     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.7.4.615     Document Type: Article

References (34)

1. LAZAR HL: Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GM) solutions. Am. J. Car-diol. (1997) 80(3A):90A–93A.
2. HOFMANN E: The significance of phosphofructoki-nase to the regulation of carbohydrate metabolism. Rev. Physiol. Biochem. Pharmacol (1976) 75: 2–68.
3. KUBLER W, SPIECKERMANN PG: Regulation of glycoly-sis in the ischemic and anoxic myocardium. J. Mol Cell Cardiol. 1: 351–377.
4. TAVAZZI B, STARNES JW, LAZZARINO G et al: Exoge-nous fructose-1,6-biphosphate is a metabolizable sub-strate for the isolated normoxic rat heart. Basic Res. Cardiol. (1992) 87: 280–289.
5. FARIAS LA, SMITH EE, MARKOV AK: Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate. Stroke (1990) 21: 606–613.
6. GREGORY GA, YU ACH, CHAN PH: Fructose-1,6-biphosphate protects astrocytes from hypoxic dam-age. Cereb. Blood Flow Metab. (1989) 9: 29–34.
7. HARDIN CD, ROBERTS TM: Metabolism of exogenously applied fructose-1,6-diphosphate in hypoxic vascular smooth muscle. Am J. Physiol. (1994) 267: H2325–H2332.
8. GREGORY GA, WELSH FA, YU ACH, CHAN PH: Fructose-1,6-biphosphate reduces ATP loss from hy-poxic astrocytes. Brain Res. (1990) 516: 310–312.
9. PAUL RJ, HARDIN CD, RAEYMAEKERS L, WUYTACK F, CASTEELS R: Preferential support of Ca2±uptake in smooth muscle plasma membrane vesicles by an en-dogenous glycolytic cascade. FASEB J. (1989) 3: 2298–2301.
10. EDDE L, ZHOU X, EATON JW, SHERMAN MP: Induction of nitric oxide synthase in macrophages: inhibition by fructose-1,6-diphosphate. BBRC (1998). (In Press.)
11. MIHAS AA, MALIAKKAL RJ, MIHAS TA, KANJI VK, MAR-KOV AK: Effects of fructose-1,6-diphosphate on the ac-tivity of rat liver nitric oxide synthase in vitro. Pharmacology (1997) 54: 43–48.
12. LAZZARINO G, NUUTINEN ME, TAVAZZI B et al.: Preserv-ing effect of fructose-1, 6-biphosphate on high-energy phosphate compounds during anoxia and reperfu-sion in isolated Langendorff-perfused rat hearts. J. Mol. Cell Cardiol (1991) 23: 13–23.
13. ZHANG JM, ZHANG FM, MA WS, FORRESTER T: Protective effects of exogenous fructose-1,6-diphosphate in car-diogenic shock. Cardiovasc. Res. (1988) 22: 927–932.
14. URSO L, BRILLANTE C, ORLANDI M, ROTUNDO M, BAL- LATI S: Evaluation of fructose-1,6-diphosphate effects on erythrocyte 2,3-diphosphoglycerate and ATP in surgical orthopedic patients. Agressologie (1982) 23: 115–117.
15. BADWEY JA, KARNOVSKY ML: Production of superox-ide and hydrogen peroxide by an NADH-oxidase in guinea pig polymorphonuclear leukocytes. J. Biol. Chem. (1979) 254: 11530–11537.
16. CACIOLI D, CLIVATI A, PELOSI P, MEGEVAND J, GALEONE M: Haemorheological effects of fructose-1,6-diphosphate in patients with lower extremity ische-mia. Curr. Med. Res. Opin. (1988) 10: 668–674.
17. TAVAZZI B, CERRONI L, DI PIERRO D et al.: Oxygen radi-cal injury and loss of high-energy compounds in an-oxic and reperfused rat heart: prevention by exogenous fructose-1,6-biphosphate. Free Rad. Res. Comm. (1990) 10: 167–176.
18. MARKOV AK, FINCH CD, HELLEMS HK: Prevention of su-peroxide generation and inhibition of oxygen burst in human canine neutrophils with fructose-1,6-diphosphate (EDP). In: Microcirculation: An Update Vol-ume 1. Tsuchiya M, Asano M, Mishima Y, Oda M (Eds.), El-sevier, Amsterdam (1987): 692–696.
19. MARKOV AK, DIDLAKE RH et al: Prevention of free radicals-induced pulmonary damage with fructose-1,6-diphosphate (EDP). Clin. Res. (1986) 34 (10): 227A.
20. JANZ TG, LEASURE J, OLSON JE: The effects of fructose-1,6-diphosphate on myocardial damage in acute coronary artery occlusion. Resuscitation (1991) 22: 45–54.
21. ANGELOS M, LEASURE J, BARTON R: Fructose-1,6-diphosphate fails to limit early myocardial infarction size in a canine model. Ann. Emerg. Med. (1993) 22: 171–177.
22. SUN J, FARIAS LA, MARKOV AK: Fructose-1,6-diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology (1990) 98: 117–126.
23. TRIMARCHI GR, DE LUCA R, CAMPO M, SCURI R, CAPUTIAP: Protective effects of fructose-1,6-biphosphate on survival and brain putrescine levels during ischemia and recirculation in the Mongolian gerbil. Stroke (1990) 21: 171–173.
24. MARCHIONNI N, CONTI A, DE ALFIERI W et al. Hemody- namic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarc-tion. Am. J. Cardiol. (1985) 56: 266–269.
25. MARKOV AK, BRUMLEY MA, FIGUEROA A, SKELTON TN, LEHAN PH: Hemodynamic effects of fructose-1,6-diphosphate in patients with normal and impaired left ventricular function. Am. Heart J (1997) 133 (5): 541–549.
26. YI WS, HONG DR: Effect of fructose-1,6-diphosphate on mortality in patients with acute myocardial infarction. Abstract submitted to American College of Cardiology 41st Scientific Session. (1992): 904–963.
27. MARCHIONNI N, MOSCHI G, DI BARI M et al.: Improved exercise tolerance by IV fructose-1,6-diphosphate in chronic stable angina pectoris. J. Clin. Pharmacol. (1988) 28: 807–811.
28. GRANDI AM, MUGGIA C, BARZIZZA F, VENCO A, FINARDI G: Improved left ventricular function after short-term treatment with fructose-1,6-diphosphate: echocardio-graphic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy. Clin. Therap. (1988) 10: 372–380.
29. MALUSARDI R, ODDONE A, ORLANDI M, MANZI G: Fructose-1,6-diphosphate in the treatment of atrial pacing induced myocardial ischemia. Minerva Cardio-angiologica (1988) 36: 439–444.
30. ODERO A, KUNKL E, CUGNASCA M, DE AMICIS P, PECIS C, MARCHETTI M: Fructose-1,6-diphosphate in peripheral vascular disease: a clinical evaluation in lower limb ischemia. Curr. Ther. Res. (1985) 38: 396–403.
31. NUUTINEN EM, LAZZARINO G, GIARDINA B, HASSINEN IE: Effect of exogenous fructose-1,6-biphosphate on glycolysis in the isolated perfused rat heart. Am. Heart J. (1991) 122: 523–527.
32. RIEDEL B, SACCO C, FOX AW, ELLIS G, ROYSTON D: Myo-cardial performance preservation by fructose-1,6-diphosphate (EDP) following cardiopulmonary by-pass. Anesthesiology (September, 1996) Abstract 85: (3A).
33. BUNN FH: Pathogenesis and treatment of sickle cell disease. New Engl. J. Med. (1997) 9: 762–769.
34. SOLOVEY A, LIN YI, BROWNE P et al.: Circulating acti-vated endothelial cells in sickle cell anemia. NewEngLJ. Med. (1997) 11: 1584–1590.